Form 4: BioLife Solutions Officer Karen A. Foster Sells Shares to Cover Tax Obligations

Karen A. Foster, Chief Quality and Operations Officer of BioLife Solutions Inc., sold 286 shares of common stock on April 9, 2025, to cover tax withholding obligations related to vesting restricted stock.

Summary

• On April 9, 2025, Karen A. Foster, Chief Quality and Operations Officer of BioLife Solutions Inc., sold 286 shares of the company's common stock.
• The sale was executed at a price of $20.11 per share.
• The transaction was conducted under a pre-arranged Rule 10b5-1(c) trading plan adopted on January 3, 2023.
• The purpose of the sale was to satisfy tax withholding obligations associated with the vesting of restricted stock.
• Following the transaction, Foster directly owns 195,567 shares of BioLife Solutions Inc.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it reports a routine stock sale for tax purposes under a pre-existing trading plan. It doesn't indicate any fundamental change in the company's prospects or insider confidence.

Industry Context

This is a routine Form 4 filing, indicating an insider transaction. It's common for executives to sell shares to cover tax obligations, especially after stock vesting. The use of a pre-arranged 10b5-1 trading plan suggests the sale was planned and not based on any inside information.

Stakeholder Impact

• The sale of shares by an officer could have a minor impact on shareholder sentiment, but the use of a 10b5-1 plan mitigates concerns about insider trading.

Key Dates

Keywords

Form 4, BioLife Solutions Inc, BLFS, Karen A. Foster, Stock Sale, Rule 10b5-1, Tax Withholding, Insider Trading